Collegium PharmaceuticalvsMerck & Company

COLL and MRK stock compared: price, dividend, valuation and results, from SEC filings.

COLL

Collegium Pharmaceutical, Inc.

$25.32

Value $804M

+1.48%
COLL's page

MRK

Merck & Company, Inc.

$147.76

Value $365B

+0.55%
MRK's page

Collegium Pharmaceutical (COLL) has a market value of $804M and Merck & Company (MRK) $365B. Over the last year, with dividends, COLL moved -46.5% and MRK +66.3%. The P/E is 21.1 for COLL and 148.9 for MRK. Dividend yield: COLL none, MRK 2.30%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    COLL$804M

    MRK$365B

    MRK is 454 times COLL

  • Revenue, 12 months

    COLL$815M

    MRK$67.4B

    MRK is 83 times COLL

  • Net income, 12 months

    COLL$38M

    MRK$2.5B

    MRK is 64 times COLL

  • Operating margin

    COLL15.2%

    MRK–

  • ROIC

    COLL19.2%

    MRK3.9%

    15.3 points apart

  • P/E

    COLL21.1

    MRK148.9

    MRK is 7.1 times COLL

  • Dividend yield

    COLL0.0%

    MRK2.3%

    2.3 points apart

  • 5-year return

    COLL+30.0%

    MRK+104.9%

    74.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

COLL+30.0%

MRK+104.9%

10020020222023202420252026
Returns by period
PeriodCOLLWith dividendsMRKWith dividends
1 year since November 12, 2025-46.5%Price -46.5%+66.3%Price +61.6%
3 years since November 13, 2023+0.5%+0.2% a yearPrice +0.5%+58.0%+16.5% a yearPrice +44.2%
5 years since November 12, 2021+30.0%+5.4% a yearPrice +30.0%+104.9%+15.4% a yearPrice +75.9%
10 years since November 15, 2016+53.3%+4.4% a yearPrice +53.3%+230.1%+12.7% a yearPrice +143.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

COLLCollegium PharmaceuticalMRKMerck & Company

Valuation

COLLMRK
Valuation
Price$25.32$147.76
Market value$804M$365B
Enterprise value (EV)–$409B
P/E21.1148.9
P/E, 5-year median19.614.8
P/B2.78.1
EV/EBIT–86.0
Free cash flow yield41.8%4.0%

Results and growth

COLLMRK
Results and growth
Revenue, 12 months$815M$67.4B
Net income, 12 months$38M$2.5B
Free cash flow, 12 months$336M$14.7B
Earnings per share, 12 months$1.20$0.98
Revenue growth, year on year23.6%1.3%
Revenue growth a year, past+20.3%over 5 years+9.4%over 5 years
EPS growth a year, past+17.9%over 5 years+21.2%over 5 years

Margins and returns on capital

COLLMRK
Margins and returns on capital
Gross margin59.1%71.8%
Operating margin15.2%–
Net margin4.7%3.6%
ROIC19.2%3.9%
ROE12.8%5.2%

Balance sheet

COLLMRK
Balance sheet
Cash$145M$9.7B
Total debt–$53.8B
Net debt / EBITDA–5.7
Interest cover1.6×2.4×

Dividends and buybacks

COLLMRK
Dividends and buybacks
Dividend yield–2.3%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield3.1%1.4%
Shareholder yield3.1%3.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: COLL or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Collegium Pharmaceutical or Merck & Company?

By market value, Merck & Company ($365B) is about 454.4 times Collegium Pharmaceutical ($804M), at today's prices.

How did COLL and MRK stock do over the last 10 years?

Since November 15, 2016, COLL's price moved +53.3% and MRK's +143.3%. With dividends: COLL +53.3% (+4.4% a year), MRK +230.1% (+12.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, COLL or MRK?

The dividend yield at today's price is none for Collegium Pharmaceutical and 2.30% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of COLL and MRK?

At today's price, the P/E is 21.1 for COLL and 148.9 for MRK. The median of the last five years was 19.6 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Collegium Pharmaceutical or Merck & Company?

Over the last twelve months, the net margin was 4.7% for Collegium Pharmaceutical and 3.6% for Merck & Company, and the operating margin 15.2% and –. Revenue was $815M and $67.4B.

Which is the better investment, Collegium Pharmaceutical or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.